|
| |
synergen pharma inc. Pages on BioPortfolio:
BioPortfolio - Synergen Incorporated
Synergen Incorporated - Entry on Bioportfolio's Biocorporate Database. ... Pharma Live: May 28 2008 2:08PM Matching: synergen ...
http://www.bioportfolio.com/biocorporate/9928-Synergen_Incor...
|
Biotechnology News Sciclone barofold. sax. jon. synergen ...
Current Search: sciclone: 47, sax: 6, jon: 286, synergen: 1, hesterberg: 1 ... SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
7.6 Amgen Completes Immunex Acquisition in 2002 7.7 Amgen Acquires Kinetix Pharmaceuticals Inc Acquisition in 2002 7.8 Amgen Acquires Synergen in 1994 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_391.html...
|
Biotechnology News Chiron rutter. synergen. bill. bio. llc. corp ...
Current Search: chiron: 125, rutter: 8, synergen: 1, bill: 3327, bio: 2121, llc: 3778, corp: 5327, ... 25 /PRNewswire/ -- RHEI Pharmaceuticals, Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...
|
Biotechnology News CNS 7056. cene. 60170. 60582. cn. thomson ...
GAITHERSBURG, Md.--(BUSINESS WIRE)-- Ore Pharmaceuticals Inc Ore Pharmaceuticals acquired the development rights for romazarit through its partnership with ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Biotechnology News CNS 7056. cene. 60170. 60582. cn. thomson ...
Ore Pharmaceuticals Inc (NASDAQ:ORXE), a commercial drug development company, declared on 31 July that the company has entered into a drug repositioning ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Biotechnology News CNS 7056. cene. 60170. 60582. cn. thomson ...
Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., itself a division of Johnson & Johnson, received approval from the FDA ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Biotechnology News CNS 7056. cene. 60170. 60582. cn. thomson ...
Ore Pharmaceuticals Acquires Repositioned Clinical-Stage Drug Candidate from Roche , 6:00 AM EST News source: Business Wire Ore Pharmaceuticals Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Biotechnology News CNS 7056. cene. 60170. 60582. cn. thomson ...
Ore Pharma acquires clinical-stage drug candidate tiapamil from Roche Ore Pharmaceuticals Inc has acquired from Roche the clinical-stage compound tiapamil. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Results from other life science and pharmaceutical sites:
Synergen lineage may finally pay off - Nature Biotechnology
Amgen bought Synergen after its interleukin-1 antagonist, Antril, ... than 160 years of combined big pharma company experience of the company's employees, ...
http://www.nature.com/nbt/journal/v17/n3/full/nbt0399_217b.h...
|
BioPortfolio - Synergen Incorporated
Synergen Incorporated - Entry on Bioportfolio's Biocorporate Database. ... Pharma Live: May 28 2008 2:08PM Matching: synergen ...
http://www.bioportfolio.com/biocorporate/9928-Synergen_Incor...
|
Amgen - About Amgen - Company History - Acquisitions
2006, Abgenix, Inc. 2004, Tularik Inc. 2002, Immunex Corporation. 2000, Kinetix Pharmaceuticals Inc. 1994, Synergen, Inc. ...
http://www.amgen.com/about/acquisitions.html...
|
Astex Therapeutics - Board
He is currently a non-executive director of Rigel Pharmaceuticals Inc. and a Pitt ... prior to which he served as President and CEO of Synergen Inc. Mr Saxe
...
http://www.astex-therapeutics.com/about/board.php...
|
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
7.6 Amgen Completes Immunex Acquisition in 2002 7.7 Amgen Acquires Kinetix Pharmaceuticals Inc Acquisition in 2002 7.8 Amgen Acquires Synergen in 1994 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_391.html...
|
When products fail - Nature Biotechnology
In the United States, Magainin Pharmaceuticals (Philadelphia, ... Despite a cash pile of $111 million, Synergen agreed to a proposed acquisition by Amgen ...
http://www.nature.com/nbt/journal/v19/n6s/full/nbt0601supp_B...
|
Patent News Peter Steele * & Matthew Sparrowhawk
as WO-08911540 in the name of Synergen Inc, this patent is. due to expire in May 2009, ... Pharmaceuticals Inc's US-06114502, published first as WO- ...
http://www.biomedcentral.com/content/pdf/cd-478370.pdf...
|
OncoMed Pharmaceuticals Appoints Paul J. Hastings President and ...
1 /PRNewswire/ -- OncoMed Pharmaceuticals, a company pioneering the ... Europe, for Synergen Inc., and previously held a series of marketing and sales ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Experimental use and the orphan drug act: A biotechnology ...
1Paul J. Koivuniemi was formerly patent counsel and general counsel at Synergen, Inc., ... Solvay Pharmaceutical, Inc., 25 USPQ2d 1344 (N.D. Georgia 1992). ...
http://www.nature.com/nbt/journal/v14/n4/abs/nbt0496-511.htm...
|
Case Studies in Allergic Disease: Key Decision Points in Diagnosis ...
Synergen, Inc. 60. Taisho Pharmaceutical Co., Ltd. 61. Tanox, Inc. 62. TAP Pharmaceuticals Inc. 63. Toray Industries, Inc. 64. UCB Pharma, Inc. ...
http://www3.niaid.nih.gov/about/organization/dait/PDF/Case_S...
|
|
